June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Investigation of the effects of topical microRNA 16-5p mimic and inhibitor in a mouse model of inflammation-related dry eye
Author Affiliations & Notes
  • Yu Jeong Kim
    ophthalmology, Hanyang University, Seongdong-gu, Seoul, Korea (the Republic of)
  • Hyun Soo Cho
    ophthalmology, Hanyang University, Seongdong-gu, Seoul, Korea (the Republic of)
  • Yeji Yeon
    ophthalmology, Hanyang University, Seongdong-gu, Seoul, Korea (the Republic of)
  • Won June Lee
    ophthalmology, Hanyang University, Seongdong-gu, Seoul, Korea (the Republic of)
  • Min Ho Kang
    ophthalmology, Hanyang University, Seongdong-gu, Seoul, Korea (the Republic of)
  • Han Woong Lim
    ophthalmology, Hanyang University, Seongdong-gu, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Yu Jeong Kim None; Hyun Soo Cho None; Yeji Yeon None; Won June Lee None; Min Ho Kang None; Han Woong Lim None
  • Footnotes
    Support  National Research Foundation of Korea (NRF) 2020R1C1C1011696
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1994 – A0324. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yu Jeong Kim, Hyun Soo Cho, Yeji Yeon, Won June Lee, Min Ho Kang, Han Woong Lim; Investigation of the effects of topical microRNA 16-5p mimic and inhibitor in a mouse model of inflammation-related dry eye. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1994 – A0324.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We previously reported that microRNA (miR) 16-5p were increased in tears of patients with Sjogren’s syndrome compared to controls. In this study, we intend to investigate the effect of topical miR-16-5p mimic and inhibitor in a mouse model of inflammation-related dry eye syndrome.

Methods : We used 11-week-old NOD.B10.H2b mice, a model for primary Sjögren's syndrome. We measured baseline ocular staining score and tear production. And we topically applied miR-16-5p mimic, miR-16-5p inhibitor or the same volume of phosphate-buffered saline (PBS) four times a day for 1 week to both eyes of the mice. Seven days later, tear production was measured, and the corneal surface was observed for epithelial defects. The number of goblet cells was evaluated in the forniceal conjunctiva. The levels of proinflammatory cytokines were analyzed in the cornea, conjunctiva, and lacrimal glands.

Results : Topical miR-16-5p mimic increased ocular staining score in NOD.B10.H2b mice than PBS. And topical miR-16-5p inhibitor administration improved tear production and reduced corneal epithelial defects. The conjunctival goblet cell density was higher in miR-16-5p inhibitor treated eyes than in miR-16-5p mimic or PBS treated eyes. Mir-16-5p mimic increased the expression of proinflammatory cytokines in the cornea, conjunctiva, and intraorbital gland and miR-16-5p inhibitor suppressed them.

Conclusions : Inhibition of miR-16-5p had the effect of protecting the ocular surface and suppressing inflammation.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×